The efficacy and the utility of switching into glucagon like peptide-1 receptor agonist plus basal insulin therapy in type 2 diabetic patients treated with Basal-Bolus therapy.
Phase of Trial: Phase IV
Latest Information Update: 23 May 2018
At a glance
- Drugs Dulaglutide (Primary) ; Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 May 2018 New trial record